Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.
Ciani O, Manyara AM, Davies P, Stewart D, Weir CJ, Young AE, Blazeby J, Butcher NJ, Bujkiewicz S, Chan AW, Dawoud D, Offringa M, Ouwens M, Hróbjartssson A, Amstutz A, Bertolaccini L, Bruno VD, Devane D, Faria CDCM, Gilbert PB, Harris R, Lassere M, Marinelli L, Markham S, Powers JH, Rezaei Y, Richert L, Schwendicke F, Tereshchenko LG, Thoma A, Turan A, Worrall A, Christensen R, Collins GS, Ross JS, Taylor RS. Ciani O, et al. Among authors: ouwens m. EClinicalMedicine. 2023 Oct 17;65:102283. doi: 10.1016/j.eclinm.2023.102283. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37877001 Free PMC article.
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
Manyara AM, Davies P, Stewart D, Weir CJ, Young AE, Wells V, Blazeby J, Butcher NJ, Bujkiewicz S, Chan AW, Collins GS, Dawoud D, Offringa M, Ouwens M, Ross JS, Taylor RS, Ciani O. Manyara AM, et al. Among authors: ouwens m. J Clin Epidemiol. 2023 Aug;160:83-99. doi: 10.1016/j.jclinepi.2023.06.013. Epub 2023 Jun 26. J Clin Epidemiol. 2023. PMID: 37380118 Free article. Review.
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
McEwan P, Gabb PD, Davis JA, Sanchez JJG, Sjöström CD, Barone S, Kashioulis P, Ouwens M, Cassimaty S, Correa-Rotter R, Rossing P, Wheeler DC, Heerspink HJL. McEwan P, et al. Among authors: ouwens m. Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093/ndt/gfae106. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 38730538
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W, Joy M, Ouwens M, Taylor KS, Venkatesan S, Dennis J, Tran TN, Dashtban A, Fan X, Williams R, Morris T, Carty L, Kar D, Hoang U, Feher M, Forbes A, Jamie G, Hinton W, Sanecka K, Byford R, Anand SN, Hobbs FDR, Clifton DA, Pollard AJ, Taylor S, de Lusignan S. Meeraus W, et al. Among authors: ouwens m. J Infect. 2024 Apr;88(4):106129. doi: 10.1016/j.jinf.2024.106129. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431156 Free article.
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron.
Meeraus W, Stuurman AL, Durukal I, Conde-Sousa E, Lee A, Maria AS, Furtado BE, Ouwens M, Gray CM, Valverde DA, da Silva HG, Taylor S. Meeraus W, et al. Among authors: ouwens m. Vaccine. 2023 Oct 6;41(42):6366-6378. doi: 10.1016/j.vaccine.2023.08.085. Epub 2023 Sep 12. Vaccine. 2023. PMID: 37704499 Free article.
112 results